Soleno Therapeutics, Inc.
SLNO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,806 | $664 | $83 | $164 |
| - Cash | $88 | $170 | $15 | $21 |
| + Debt | $53 | $0 | $0 | $0 |
| Enterprise Value | $1,771 | $495 | $69 | $143 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$174 | -$37 | -$22 | -$30 |
| % Margin | – | – | – | – |
| Net Income | -$176 | -$39 | -$24 | -$31 |
| % Margin | – | – | – | – |
| EPS Diluted | -4.38 | -2.36 | -2.87 | -5.81 |
| % Growth | -85.6% | 17.8% | 50.6% | – |
| Operating Cash Flow | -$69 | -$25 | -$21 | -$28 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$69 | -$25 | -$21 | -$28 |